J. Shashidhar
YOU?
Author Swipe
View article: PHARMACEUTICO-ANALYATICAL STUDY OF KUSHMANDA GHRITHA ANDASSESSMENT OF ITS ANTI CONVULSANT ACTIVITY ON ALBINO MICE
PHARMACEUTICO-ANALYATICAL STUDY OF KUSHMANDA GHRITHA ANDASSESSMENT OF ITS ANTI CONVULSANT ACTIVITY ON ALBINO MICE Open
Sneha Kalpana are the formulations where Ghrita and Taila are used as base to extract water soluble and lipid soluble active principles. Ghrita is considered as the best Sneha Dravya because of its speciality ie, “Samskarasyaanuvartanam” m…
View article: Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2 Open
Despite effective vaccination programs, waning immunity in the vaccinated populations and the emergence of variants of concern posed a risk of breakthrough infections. A booster dose was demonstrated to provide substantially increased prot…
View article: Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients Open
View article: Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine
Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine Open
View article: Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals Open
View article: Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time
Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time Open
Background and Aims: Long-term data on cell-based therapies, including hematopoietic stem cell infusion in cirrhosis, are sparse and lacking. Methods: Patients with cirrhosis of non-viral etiology received eithe…